Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals

Clinical trial NCT00218413 · COMPLETED

Trial details

NCT number: NCT00218413
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation Tobacco Use Cessation

Start date: 2004-10-01
Primary completion: 2006-08-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.